[Effect of neovir in the treatment of acute hepatitis C]

Zh Mikrobiol Epidemiol Immunobiol. 2001 May-Jun:(3):84-7.
[Article in Russian]

Abstract

Fifteen male patients with acute hepatitis C aged 16-44 years were treated with neovir, an interferon inducer, administered intramuscularly in a daily dose of 250 mg 2-3 times a week for 3 months. By the end of this therapy the RNA of hepatitis C virus could still be detected in 84.6% of the patients, the characteristics of ALT, AST and alkaline phosphatase exceeded the norm more than twofold. The results of neovir therapy are regarded as ineffective.

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Acridines / therapeutic use*
  • Acute Disease
  • Hepacivirus / genetics
  • Hepatitis C / drug therapy*
  • Humans
  • Interferon Inducers / therapeutic use*
  • Male
  • RNA, Viral / blood
  • Transaminases / blood

Substances

  • Acridines
  • Interferon Inducers
  • RNA, Viral
  • Camedon
  • Transaminases